相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Indoleamine 2,3 Dioxygenase-Mediated Tryptophan Catabolism Regulates Accumulation of Th1/Th17 Cells in the Joint in Collagen-Induced Arthritis
Gabriel Criado et al.
ARTHRITIS AND RHEUMATISM (2009)
Tolerization With Hsp65 Induces Protection Against Adjuvant-Induced Arthritis by Modulating the Antigen-Directed Interferon-gamma, Interleukin-17, and Antibody Responses
Shailesh R. Satpute et al.
ARTHRITIS AND RHEUMATISM (2009)
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
David J. Chung et al.
BLOOD (2009)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
Madhav D. Sharma et al.
BLOOD (2009)
Interferon-γ-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells
Birgit Juergens et al.
BLOOD (2009)
Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer
Aaron S. Mansfield et al.
BMC CANCER (2009)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Feng Qian et al.
CANCER RESEARCH (2009)
The Importance of NAD in Multiple Sclerosis
W. Todd Penberthy et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis
C. Coquerelle et al.
GUT (2009)
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
Tomoko Inaba et al.
GYNECOLOGIC ONCOLOGY (2009)
Induction of IDO by Bacille Calmette-Guerin Is Responsible for Development of Murine Depressive-Like Behavior
Jason C. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2009)
Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
Manuela Brenk et al.
JOURNAL OF IMMUNOLOGY (2009)
Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression
Hanzhong Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
Grant N. Scott et al.
JOURNAL OF IMMUNOLOGY (2009)
Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity
Alexandre S. Almeida et al.
JOURNAL OF IMMUNOLOGY (2009)
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells
Babak Baban et al.
JOURNAL OF IMMUNOLOGY (2009)
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
Carole Guillonneau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
S. Rutella et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation
Gerald Brandacher et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2008)
Toxicology and pharmacokinetics of 1-methyl-D-tryptophan: Absence of toxicity due to saturating absorption
Lee Jia et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Th17 cell differentiation: The long and winding road
Mandy J. McGeachy et al.
IMMUNITY (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells
Ghassan J. Maghzal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Ke Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans
Elin Jaensson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation
Wei Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism
Maniola Matysiak et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Luigina Romani et al.
NATURE (2008)
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation
Hui Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
Ciriana Orabona et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
Alexander J. Muller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Creating immune privilege: active local suppression that benefits friends, but protects foes
Andrew L. Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothee Duluc et al.
BLOOD (2007)
Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer
Maider Zabala et al.
JOURNAL OF HEPATOLOGY (2007)
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma
Rainer Riesenberg et al.
CLINICAL CANCER RESEARCH (2007)
IDO expression in the brain: a double-edged sword
Erik Kwidzinski et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis
Tolmoko Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells
Marcelo Hill et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse
Vijay Saxena et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Ursula Grohmann et al.
NATURE MEDICINE (2007)
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Adriano Boasso et al.
BLOOD (2007)
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
Antonio Curti et al.
BLOOD (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19(+) dendritic cells
Anna K. Manlapat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
CD40Ig treatment results in allograft acceptance mediated by CD8(+)CD45RC(low) T cells, IFN-gamma, and indoleamine 2,3-dioxygenase
Carole Guillonneau et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tryptophan catabolism in IDO+ plasmacytoid dendritic cells
Francesca Fallarino et al.
CURRENT DRUG METABOLISM (2007)
Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection
Alexey Popov et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A historical perspective on immunological privilege
Elizabeth Simpson
IMMUNOLOGICAL REVIEWS (2006)
The importance of regional lymph nodes for mucosal tolerance
Georg Kraal et al.
IMMUNOLOGICAL REVIEWS (2006)
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
Michael S. von Bergwelt-Baildon et al.
BLOOD (2006)
Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: Implications for the control of alloresponses
SC Beutelspacher et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury
HZ Liu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Crystal structure of human indoleamine 2,3-dioxygenase:: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase
H Sugimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Essay - Dendritic cells in a mature age
Caetano Reis e Sousa
NATURE REVIEWS IMMUNOLOGY (2006)
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12
C Orabona et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
F Fallarino et al.
INTERNATIONAL IMMUNOLOGY (2005)
Essential role for CD103 in the T cell-mediated regulation of experimental colitis
O Annacker et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation
B Baban et al.
INTERNATIONAL IMMUNOLOGY (2005)
Cutting edge: Silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant
C Orabona et al.
JOURNAL OF IMMUNOLOGY (2005)
Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation
E Kwidzinski et al.
FASEB JOURNAL (2005)
Dendritic cells have the option to express IDO-mediated suppression or not
DH Munn et al.
BLOOD (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells
DH Munn et al.
JOURNAL OF IMMUNOLOGY (2004)
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific
B Baban et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase
KA Swanson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
Activation requirements for the induction of CD4+CD25+ T cell suppressor function
AM Thornton et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
D von Bubnoff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cutting edge: Human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase
SO Odemuyiwa et al.
JOURNAL OF IMMUNOLOGY (2004)
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice
F Fallarino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase
AL Mellor et al.
INTERNATIONAL IMMUNOLOGY (2004)
Modulation of tryptophan catabolism by regulatory T cells
F Fallarino et al.
NATURE IMMUNOLOGY (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma
JR Lee et al.
LABORATORY INVESTIGATION (2003)
Cutting edge: Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2003)
Mucosal CD8α+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties
J Bilsborough et al.
IMMUNOLOGY (2003)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
DH Munn et al.
SCIENCE (2002)
Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis
K Sakurai et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
IL-6 inhibits the tolerogenic function of CD8α+ dendritic cells expressing indoleamine 2,3-dioxygenase
U Grohmann et al.
JOURNAL OF IMMUNOLOGY (2001)
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy
AL Mellor et al.
NATURE IMMUNOLOGY (2001)
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
P Hwu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
